Serving hundreds of leading biopharmaceutical companies globally:

Generated: October 17, 2018

DrugPatentWatch Database Preview

Apothecon Company Profile

« Back to Dashboard

What is the competitive landscape for APOTHECON, and what generic and branded alternatives to APOTHECON drugs are available?

APOTHECON has one hundred and fourteen approved drugs.

There are three tentative approvals on APOTHECON drugs.

Summary for Apothecon

US Patents:	0
Tradenames:	77
Ingredients:	47
NDAs:	114

Drugs and US Patents for Apothecon

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apothecon	VELOSEF	cephradine	INJECTABLE;INJECTION	061976-004	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	ENALAPRIL MALEATE	enalapril maleate	TABLET;ORAL	075583-004	Aug 22, 2000		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	AMPICILLIN SODIUM	ampicillin sodium	INJECTABLE;INJECTION	062860-005	Feb 5, 1988		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	LABETALOL HYDROCHLORIDE	labetalol hydrochloride	TABLET;ORAL	075223-001	Nov 20, 1998		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	CEPHALEXIN	cephalexin	FOR SUSPENSION;ORAL	062987-001	Jul 25, 1989		DISCN	No	No		➤ Sign Up				➤ Sign Up
Apothecon	OPHTHAINE	proparacaine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	008883-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No		➤ Sign Up				➤ Sign Up
Apothecon	TRIMOX	amoxicillin	FOR SUSPENSION;ORAL	062154-002	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for Apothecon

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Apothecon	CAPOZIDE 25/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-001	Oct 12, 1984	4,217,347	➤ Sign Up
Apothecon	STADOL PRESERVATIVE FREE	butorphanol tartrate	INJECTABLE;INJECTION	017857-001	Approved Prior to Jan 1, 1982	3,819,635	➤ Sign Up
Apothecon	CAPOZIDE 50/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-004	Oct 12, 1984	4,105,776	➤ Sign Up
Apothecon	CAPOZIDE 50/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-004	Oct 12, 1984	4,217,347	➤ Sign Up
Apothecon	KLOTRIX	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	017850-001	Approved Prior to Jan 1, 1982	4,140,756	➤ Sign Up
Apothecon	CAPOZIDE 25/15	captopril; hydrochlorothiazide	TABLET;ORAL	018709-001	Oct 12, 1984	4,105,776	➤ Sign Up
Apothecon	CAPOZIDE 25/25	captopril; hydrochlorothiazide	TABLET;ORAL	018709-002	Oct 12, 1984	4,105,776	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission

Merck

Cantor Fitzgerald

Citi

Teva

Daiichi Sankyo

Harvard Business School

AstraZeneca

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.